Sun X, Bristol JA, lwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J Virol, 2013. 87(18): p. 10126-38.
Sun X, Kenney SC. Hsp90 inhibitors: a potential treatment for latent EBV infection? Cell Cycle, 2010. 9(9): p. 1665-6.
Sun X, Barlow EA, Ma S, Hagemeier SR, Duellman SJ, Burgess RR, Tellam J, Khanna R, Kenney SC. Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proc Natl Acad Sci U S A, 2010. 107(7): p. 3146-51.